Updated Payment and Utilization Policies
Date: 12/22/20
Thank you for your continued partnership with Trillium Community Health Plan. As you know, we continually review and update our payment and utilization policies to ensure that they are designed to comply with industry standards while delivering the best patient experience to our members. We are writing today to inform you of new policies Trillium Community Health Plan will be implementing effective 04/01/2021.
Number | Policy Name | Policy Description | Line of Business (LOB) |
CP.MP.38 | Ultrasound in Pregnancy | Ultrasounds during pregnancy are considered medically necessary when the conditions and frequency outlined in the policy are met. | Medicaid Medicare |
CP.MP.97 | Testing for Select GU Conditions | Certain diagnostic tests for symptomatic women for the evaluation of vaginitis are medically necessary for members age ≥ 13 based on the indications outlined in the policy. | Medicaid Medicare |
CP.MP.106 | Endometrial Ablation | The treatment for endometrial ablation is considered experimental or investigational if it is photodynamic endometrial ablation or for treatment for all other conditions than those specified in the policy. | Medicaid Medicare |
CP.MP.113 | Holter Monitors | Holter Monitoring (CPT codes 93224, 93225, 93226, and 93227) is considered medically necessary for adult and pediatric members who require 24 to 48 hours of cardiac activity monitoring with any of the indications listed in the policy. | Medicaid Medicare |
CP.MP.121 | Homocysteine Testing | Homocysteine testing is considered medically necessary for the following indications: borderline vitamin B12 deficiency, homocystinuria caused by cystathionine beta-synthase deficiency, or Idiopathic venous thromboembolism, recurrent venous thromboembolism, thrombosis occurring at less than 45 years of age, or thrombosis at an unusual site | Medicaid |
CP.MP.125 | DNA Analysis of Stool to Screen for Colorectal Cancer | Code 81528 is considered medically necessary every three years if member is 50-85 years old, asymptomatic and at average risk of colon cancer, and is not within the standard interval of another screening test for colon cancer. | Medicaid Medicare |
CP.MP.149 | Testing for Rupture of Fetal Membranes | AmniSure, Actim PROM and the ROM Plus Fetal Membranes Rupture Test (tests billed with CPT® code 84112) are not medically necessary for members as they have not been shown to improve clinical outcomes over standard methods of diagnosis. | Medicaid Medicare |
CP.MP.152 | Measurement of Serum 1,25-dihydroxyvitamin D | Measurement of serum 1,25-dihydroxyvitamin D is considered medically necessary when submitted with diagnosis codes for certain inherited disorders of vitamin D and phosphate metabolism. | Medicaid Medicare |
CP.MP.153 | H Pylori Serology Testing | Code 86677 will not be paid because it is not medically necessary. | Medicaid Medicare |
CP.MP.154 | Thyroid Hormones and Insulin Testing in Pediatrics | Deny thyroid function tests and insulin level testing in healthy, or obese but otherwise healthy, children 1-18 years of age. This is because slightly elevated levels of TSH in obesity are more likely a consequence of obesity than true hypothyroidism and there are significant limitations in the use of insulin levels as a marker of insulin resistance. | Medicaid Medicare |
CP.MP.156 | Cardiac Biomarker Testing for Acute Myocardial Infarction | Troponin I or T testing is medically necessary and appropriate for evaluating acute myocardial infarctions. It is the policy that creatin kinase myocardial isoenzyme (CK-MB) and myoglobin testing are not medically necessary in the evaluation for suspected acute myocardial infarctions because troponin is the recommended biomarker due to its superior sensitivity and accuracy. | Medicaid Medicare |
CP.MP.157 | 25-hydroxyvitamin D Testing in Children and Adolescents | It is the policy that although a 25-hydroxyvitamin D concentration, reflecting both vitamin D synthesis and intake, is the correct screening lab to monitor for vitamin D deficiency, is not necessary or safe because current evidence when testing otherwise healthy children who are overweight or obese is not sufficient. | Medicaid Medicare |
For more detailed information about these policies, please refer to our website at https://www.trilliumohp.com/providers/resources/clinical-payment-policies2.html.
For questions about this or any of our payment policies, please don’t hesitate to reach out to our Trillium Provider Services team at 1-877-600-5472 (OHP/Medicaid) or 1-844-867-1156 (Medicare).